GlassScriptPhysician profile
Braden Bizon
NPI 1093580557
$6,715.80
in general payments reported to CMS, 2019-2025
37 companies · $4,948 in 2025
The $4,948 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $130 · 2024: $1,638 · 2025: $4,948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,715.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,037.24 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $799.96 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $487.32 | 2025 | |
| Amgen INC. | $376.59 | 2024-2025 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $319.32 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Corcept Therapeutics | $259.73 | 2025 | Korlym |
| Lilly USA, LLC | $249.13 | 2025 | Zepbound, Mounjaro, Jardiance |
| Dermavant Sciences, INC. | $243.35 | 2024 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $239.68 | 2023-2024 | Sotyktu |
| Merck Sharp & Dohme LLC | $237.77 | 2024-2025 | Capvaxive, Gardasil 9, Vaxneuvance |
| Janssen Biotech, INC. | $227.75 | 2024-2025 | Tremfya |
| Incyte Corporation | $226.74 | 2024 | Opzelura |
| Aimmune Therapeutics, INC. | $206.45 | 2024-2025 | Zenpep |
| Exact Sciences Corporation | $189.25 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $186.47 | 2024-2025 | Veozah |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Braden Bizon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.